This post was originally published on this site According to a review study published in Frontiers in Pharmacology, dietary plant-based molecules that possess antioxidant properties called polyphenols can aid in the management of benign prostatic hyperplasia (BPH). However, these compounds cannot replace the need for existing therapies, surgical or pharmacological, as an effective treatment of this condition.…
About Cancer
Cancer, also called malignancy, is an abnormal growth of cells with the potential to invade or spread to surrounding tissues and structures found within the body. There are more than 100 types of cancer. A few examples include breast cancer, skin cancer, lung cancer, colon cancer, prostate cancer, and lymphoma. According to the American Cancer Society, 4 out of 10 people will be diagnosed with some form of cancer in their lifetime. Cancer prevalence has given rise to multiple medical specialties focused on symptom management and disease management. Current treatment options depending on the form of cancer include chemotherapy, radiation, blood or bone marrow transfusions, and/or surgery. Lifetime prognosis of cancer mortality is dependent on the type of cancer and is heavily conditional to early detection.
Conditions
Cancer News
SciFluor Life Sciences to Initiate Clinical Trials for 2 Retinal Diseases
This post was originally published on this site SciFluor Life Sciences announced that an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) is now in effect for SF0166 Topical Ophthalmic Solution, enabling the company to begin clinical trials in patients with wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Allied Minds’…
New Type 2 Diabetes Treatment, Adlyxin, Approved for Use in US
This post was originally published on this site The U.S. Food and Drug Administration (FDA) approved Adlyxin (lixisenatide) as a new treatment for type 2 diabetes this week. The treatment consists of a daily injection that, combined with diet and exercise, can control blood sugar levels in adults with this common type of diabetes. Adlyxin is a…
Immunotherapy Helps Myeloma Patients Who Relapse After Stem Cell Transplant, Study Shows
This post was originally published on this site Many patients with blood cancers, such as myeloma, go into remission after receiving a stem-cell transplant. However, there are still many patients (about one-third) who relapse, a condition usually associated with a poor prognosis. Dana-Farber Cancer Institute researchers tested the effects of a new treatment approach using repeated doses of the immunotherapy drug Yervoy…
AstraZeneca Highlights Respiratory Medicines at ATS 2016
This post was originally published on this site AstraZeneca is presenting a broad selection of its novel respiratory disease medicines through more than 60 abstracts and scientific presentations at the American Thoracic Society (ATS) 2016 International Conference through May 18 in San Francisco, Calif. Presentations highlight combinations, respiratory biologics, and scientific research projects that target new…
Partial Breast Radiation as Effective as Entire Breast Radiotherapy in Low-Risk Cancers, UK Study Reports
This post was originally published on this site Radiotherapy after breast cancer surgery that’s limited to former tumor sites is just as effective in treating early cancers as whole breast radiation and has fewer long-term side effects, according to results of a clinical study presented at the recent 10th European Breast Cancer Conference. The trial, called IMPORT LOW and supported…
Relapsed, Refractory Multiple Myeloma Progression Free Survival Prolonged with Drug Combo
This post was originally published on this site Elotuzumab in combination with bortezomib and dexamethasone prolongs the progression free survival of patients with relapsed or refractory multiple myeloma (RRMM), according to the study “Randomized phase 2 study of elotuzumab plus bortezomib/dexamethasone (Bd) versus Bd for relapsed/refractory multiple myeloma,” recently published in Blood. Current choices of care for the treatment…
Thalidomide Seen as Superior Pre-Stem Cell Transplant Therapy for Multiple Myeloma
This post was originally published on this site A three-drug combination that includes thalidomide, in place of cyclophosphamide, prior to an autologous stem cell transplant was seen to improve response rates in multiple myeloma patients, according to the conclusions of a randomized, open-label Phase 3 trial, titled “VTD is superior to VCD prior to intensive therapy in multiple…
FDA Names Darzalex ‘Breakthrough Therapy’ for Previously Treated Multiple Myeloma Patients
This post was originally published on this site The U.S. Food and Drug Administration has designated Darzalex (daratumumab), in combination with standard-of-care regimens, a breakthrough therapy for people with previously treated multiple myeloma (MM), speeding its clinical development and regulatory review for these patients. The FDA designation is reserved for treatments showing early evidence in clinical studies of substantial improvement over existing therapies. Darzalex…
Drug Combo for Multiple Myeloma Fails in Overall Patient Survival
This post was originally published on this site A randomized Phase 3 clincal trial has concluded that combining bortezomib (Velcade) with pegylated liposomal doxorubicin (PLD) does not show benefit in treating relapsed or refractory multiple myeloma (MM) patients, compared to bortezomib alone. The data was published in Cancer under the title “Final overall survival results of a randomized…
FDA approves MRI-guided focused ultrasound device to treat tremor
This post was originally published on this site The FDA published the approval of the first focused ultrasound device for the treatment of essential tremor in people who did not respond to treatment. Magnetic resonance (MR) images are taken by ExAblate Neuro during application of focused ultrasound to kill the brain cells which are considered…
1 Million Patients Treated with Leksell Gamma Knife Surgery — a Milestone for Elekta
This post was originally published on this site World neurosurgery leaders gathered in Amsterdam May 15-19 for the 18th International Leksell Gamma Knife Society Meeting. The annual conference is dedicated to Gamma Knife surgery in the treatment of intracranial disorders, and covers topics such as radiosurgery, benign tumors, vascular disorders, malignant tumors, ophthalmological disorders, functional…